Aug 13, 2019
Immunovant Appoints Robert K. Zeldin, M.D. as Chief Medical Officer and W. Bradford Middlekauff, J.D. as General Counsel
Aug 05, 2019
Altavant Sciences Initiates Phase 2a Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension
Jun 05, 2019
Immunovant Appoints Pete Salzmann as Chief Executive Officer
May 23, 2019
Immunovant Initiates Dosing in ASCEND-GO 1, a Phase 2a Trial of IMVT-1401 in Patients with Graves' Ophthalmopathy (GO)
May 14, 2019
Roivant Statement on Positive Phase 3 Results from Myovant's LIBERTY 1 Study in Uterine Fibroids
May 09, 2019
Altavant Sciences to Provide Corporate and Clinical Update at 2019 Respiratory Innovation Summit
Apr 04, 2019
Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia
Mar 21, 2019
Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations
Mar 19, 2019
Roivant Statement on Topline Results from EMPOWUR Phase 3 Study in Overactive Bladder
Mar 05, 2019
Myovant Sciences to Present at Upcoming Investor Conferences
Feb 21, 2019
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
Feb 07, 2019
Myovant Provides Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2018
Jan 06, 2019
Roivant Announces Corporate Updates and Webcast of Presentation at 37th Annual J.P. Morgan Healthcare Conference
Jan 02, 2019
Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 20, 2018
Myovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
Nov 26, 2018
Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children's Hospital Medical Center
Nov 19, 2018
Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200
Nov 15, 2018
Myovant Sciences to Participate in Two Upcoming Investor Conferences
Nov 13, 2018
Roivant Sciences Announces $200 Million Investment Round
Nov 07, 2018
Myovant Strengthens Management Team and Adds New Directors to the Board